P-6191
Blood Advances | 2025
Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia.
Levis, MJ, Hamandani, M, Logan, BR, Jones, RJ, Singh, AK, Litzow, MR, Wingard, JR, Papadopoulos, EB, Perl, AE, Soiffer, RJ, Ustun, C, Oshima, MU, Uy, GL, Waller, EK, Vasu, S, Solh, MM, Mishra, A, Muffly, LS, Kim, H, Stelljes, M, Najima, Y, Onozawa, M, Thomson, KJ, Chen, C, Hasabou, N, Rosales, M, Hill, JE, Gill, SC, Nuthethi, R, King, D, Mendizabal, AM, Devine, SM, Horowitz, MM, Chen, Y
PubMed
PMID: 40590852
CIBMTR Study #: BMT1506